Thomas G. Knight

1.4k total citations
64 papers, 712 citations indexed

About

Thomas G. Knight is a scholar working on Economics and Econometrics, Epidemiology and Emergency Medicine. According to data from OpenAlex, Thomas G. Knight has authored 64 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 16 papers in Epidemiology and 13 papers in Emergency Medicine. Recurrent topics in Thomas G. Knight's work include Economic and Financial Impacts of Cancer (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Emergency and Acute Care Studies (12 papers). Thomas G. Knight is often cited by papers focused on Economic and Financial Impacts of Cancer (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Emergency and Acute Care Studies (12 papers). Thomas G. Knight collaborates with scholars based in United Kingdom, United States and Spain. Thomas G. Knight's co-authors include Julie Irving, Daniel Lasserson, Tim Cooksley, Hyman B. Muss, Jeannette T. Bensen, Grant R. Williams, Mark Holland, Allison M. Deal, Seul Ki Choi and Stacie B. Dusetzina and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Thomas G. Knight

52 papers receiving 706 citations

Peers

Thomas G. Knight
Nicole Engel-Nitz United States
Colin Rodgers United Kingdom
Lionel Pinto United States
Joel Wallace United States
Rolin L. Wade United States
Cunlin Wang United States
Bess T. Schoen United States
Douglas L. Nguyen United States
Thomas G. Knight
Citations per year, relative to Thomas G. Knight Thomas G. Knight (= 1×) peers Christopher Blanchette

Countries citing papers authored by Thomas G. Knight

Since Specialization
Citations

This map shows the geographic impact of Thomas G. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Knight more than expected).

Fields of papers citing papers by Thomas G. Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Knight. The network helps show where Thomas G. Knight may publish in the future.

Co-authorship network of co-authors of Thomas G. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Knight. A scholar is included among the top collaborators of Thomas G. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Knight. Thomas G. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atkin, Catherine, Tim Cooksley, Mark Holland, et al.. (2025). Provision of medical same day emergency care services within the UK: analysis from the Society for Acute Medicine Benchmarking Audit. BMJ Open. 15(4). e094580–e094580. 1 indexed citations
2.
Kamwa, Vicky, Thomas G. Knight, Catherine Atkin, et al.. (2024). Acute frailty services: results of a national day of care survey. BMC Geriatrics. 24(1). 608–608. 4 indexed citations
3.
Boselli, Danielle, Issam S. Hamadeh, Nikolai A. Podoltsev, et al.. (2024). Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice. Annals of Hematology. 103(8). 2837–2843.
4.
Canavan, C., Thomas G. Knight, Nilay Shah, et al.. (2024). Oral Azacitidine Maintenance Therapy in Acute Myeloid Leukemia after Frontline Hypomethylating Agent and Venetoclax. Blood. 144(Supplement 1). 6036–6036.
5.
Knight, Thomas G., et al.. (2023). Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions. Current Hematologic Malignancy Reports. 18(5). 158–166. 3 indexed citations
7.
Atkin, Catherine, Thomas G. Knight, Tim Cooksley, et al.. (2023). Performance of admission pathways within acute medicine services: Analysis from the Society for Acute Medicine Benchmarking Audit 2022 and comparison with performance 2019 - 2021. European Journal of Internal Medicine. 118. 89–97. 5 indexed citations
8.
Knight, Thomas G., Danielle Boselli, Jing Ai, et al.. (2023). Enhanced Support Services Including Nurse Navigation Mitigate Socioeconomic Disparities in the Treatment of Patients with Acute Lymphoblastic Leukemia. Blood. 142(Supplement 1). 5078–5078. 1 indexed citations
9.
Knight, Thomas G., et al.. (2023). Geographic variation in point of care ultrasound provision: results from a national audit. The Ultrasound Journal. 15(1). 16–16.
10.
Barker, Robert, Catherine Atkin, Barbara Hanratty, et al.. (2023). National Early Warning Scores Following Emergency Hospital Transfer: Implications for Care Home Residents. Journal of the American Medical Directors Association. 24(5). 653–656. 2 indexed citations
11.
Ragon, Brittany Knick, Danielle Boselli, Nilay Shah, et al.. (2023). Neighborhood Disadvantage Is Associated with Inferior Overall Survival for Acute Myeloid Leukemia Patients Treated with Standard Intensive Induction. Blood. 142(Supplement 1). 3799–3799.
13.
Knight, Thomas G., Myra Robinson, Jing Ai, et al.. (2022). Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy. JCO Oncology Practice. 18(9). e1494–e1504. 43 indexed citations
14.
Knight, Thomas G., et al.. (2022). Point-of-care lung ultrasound in the assessment of COVID-19: results of a UK multicentre service evaluation. Acute Medicine Journal. 21(3). 131–138. 2 indexed citations
15.
Holland, Mark, et al.. (2020). Society for Acute Medicine Benchmarking Audit 2019 (SAMBA19): Trends in Acute Medical Care. Acute Medicine Journal. 19(4). 209–219. 14 indexed citations
16.
Inada-Kim, Matthew, et al.. (2020). The prognostic value of national early warning scores (NEWS) during transfer of care from community settings to hospital: a retrospective service evaluation. BJGP Open. 4(2). bjgpopen20X101071–bjgpopen20X101071. 15 indexed citations
17.
Knight, Thomas G., Myra Robinson, Michael R. Grunwald, et al.. (2018). Patient Reported Financial Toxicity in Acute Leukemia. Blood. 132(Supplement 1). 4796–4796. 9 indexed citations
18.
Grunwald, Michael R., Danielle Boselli, Lauren Bohannon, et al.. (2017). Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia. Blood. 130. 3864–3864. 2 indexed citations
19.
Bebb, James R., et al.. (2006). Long‐term follow‐up of coeliac disease – what do coeliac patients want?. Alimentary Pharmacology & Therapeutics. 23(6). 827–831. 59 indexed citations
20.
Knight, Thomas G., et al.. (2002). Specialists in Public Health. Proceeding to PartII FPHM Membership. Kent Academic Repository (University of Kent). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026